Carbocysteine

Carbocysteine is a medicine used to help clear mucus from the airways. It is sometimes used in nasal sprays to help with colds or other respiratory issues. It helps thin the mucus, making it easier to cough up.

Brand names:Mucodyne
Medication

What people taking Carbocysteine report

Every report comes from a Lived member, sent anonymously.

Have you tried Carbocysteine for COPD?

NameHow it went

About Carbocysteine

What It's For

Carbocysteine (spelled carbocisteine in the UK, where it is sold under the brand name Mucodyne) is a prescription mucolytic, a medicine that makes phlegm thinner and less sticky so it is easier to cough up. It is used mainly in chronic obstructive pulmonary disease (COPD), the long-term lung disease that includes chronic bronchitis, for people who bring up thick phlegm most days. UK labeling describes it as an add-on treatment for breathing conditions with excess sticky mucus, and the UK's National Health Service (NHS) also lists cystic fibrosis among the conditions where it may help. Carbocysteine is taken alongside a person's usual lung treatment, such as inhalers, not instead of it. It has not been approved by the US Food and Drug Administration (FDA) for use in the United States. It is licensed in the UK and used in several other countries, including China, where its largest trial took place, so American readers are most likely to meet it through care abroad or through COPD research.

How It Works

When the airways are repeatedly irritated, as they are in COPD, the lining produces more mucus, and that mucus becomes thicker and stickier. Thick mucus is hard to clear, which is why many people with COPD have a daily wet cough. Carbocysteine changes the makeup of the mucus the airway glands release, so it is less viscous, and studies in people show it reduces the overgrowth of mucus-producing cells in the airway lining. Thinner mucus is moved out more easily by the tiny hairs that line the airways and by coughing. Researchers think carbocysteine may also have antioxidant and anti-inflammatory effects, which could help explain why it modestly reduces COPD flare-ups. That part of the explanation is less certain than its effect on mucus.

Dosage & Administration

Carbocysteine is taken by mouth, usually three or four times a day, with or without food. Adults most often use 375 mg capsules, swallowed whole: typically two capsules three times a day at first, then one capsule four times a day once symptoms improve. Syrup, oral liquid and single-dose sachets are available for people who find capsules hard to swallow. Some liquid versions contain alcohol and are meant only for adults. Children aged 2 and over take the syrup or liquid, with a dose based on age and measured with the syringe or spoon supplied rather than a kitchen teaspoon. It should not be given to children under 2. If a dose is missed, take it when remembered unless the next one is due within 2 hours, and never take two doses together. Taking too much usually causes no symptoms; an upset stomach or vomiting after an extra dose is a reason to call for advice.

Side Effects

The most common side effects are digestive: nausea, diarrhea, vomiting and stomach discomfort, which affect up to about 1 in 10 people. Taking the medicine after food may ease nausea. Because carbocysteine loosens mucus, coughing up more phlegm is an expected effect rather than a sign that something is wrong. Rash, headache and dizziness are less common. Rarely, carbocysteine has been linked to bleeding in the stomach or intestine. Vomiting blood or passing black, tarry stools means stopping the medicine and getting medical advice the same day. People with asthma who notice new wheezing or chest tightness after starting it should stop and contact their prescriber, since it can occasionally trigger narrowing of the airways. A serious allergic reaction (anaphylaxis) is rare. Sudden swelling of the lips, tongue or throat, or difficulty breathing, needs emergency care: call 911. A blistering or peeling rash, which can signal a rare severe skin reaction, also needs urgent medical attention.

Interactions & Warnings

Carbocysteine should not be used by people with an active stomach or duodenal ulcer. Extra caution applies to older adults, anyone who has had an ulcer, and people taking other medicines that can irritate the stomach lining or cause bleeding. These include NSAIDs (anti-inflammatory pain relievers such as ibuprofen, naproxen or high-dose aspirin), corticosteroid tablets, and antiplatelet medicines that help prevent blood clots, such as clopidogrel or low-dose aspirin. Cough suppressants are generally not recommended with carbocysteine, because the medicine works by helping the airways clear mucus and blocking the cough works against that. People who are very frail or have severe respiratory failure may not be able to cough up the loosened secretions effectively, so the prescriber needs to weigh this before using it. Carbocysteine is not recommended in the first three months of pregnancy, because there is little information on its safety for a developing baby. Little is known about use while breastfeeding, though the NHS considers it usually acceptable when the baby is healthy. Liquid forms differ in their ingredients, and some contain sugar or alcohol, so the pharmacist can help choose a suitable one.

What to Expect

Carbocysteine starts acting on mucus right away, but it can take a while to notice easier coughing and less phlegm. UK COPD guidance advises continuing it only if cough and phlegm improve, and the NHS notes that a prescriber may stop it if it does not seem to help after about a month. The realistic benefit is modest. A large review of mucolytic trials in COPD and chronic bronchitis found that about 8 people needed to take one for around nine months for one extra person to avoid a flare-up (a period when breathlessness, cough and phlegm get worse and often need extra treatment). Days of illness, and possibly hospital stays, fell slightly, but lung function and overall quality of life changed little, and newer, longer trials showed smaller benefits than older ones. In one large trial in China of people with frequent flare-ups, carbocysteine lowered them from about 1.35 to 1.01 per person per year. UK guidance does not recommend mucolytics routinely just to prevent flare-ups in stable COPD. For people who do benefit, it is often taken long term, and there is no evidence that extended use causes harm. It works as one part of COPD care that also includes stopping smoking, inhaled treatment, vaccinations and pulmonary rehabilitation (a supervised exercise and education program).

Questions to Ask Your Doctor

  1. 1.Would carbocysteine add something to my current COPD treatment, or are other options more likely to help my cough and flare-ups?
  2. 2.How will we judge whether it is working, and when should I stop if it is not?
  3. 3.Do any of my other medicines, such as pain relievers, steroids or blood thinners, raise my risk of stomach bleeding with it?
  4. 4.Which form suits me best, and if I live in the US, what similar options are available to me?

Last reviewed • Oct 2026

Educational content, not medical advice.